The aim of this study was to examine the influence of the systemic ren
in-angiotensin system on the gene expression of atrial natriuretic pep
tide in rat hearts. The renin-angiotensin system was stimulated (1) by
unilateral renal artery clipping (0.2-mm clip, 2 days), producing a f
ourfold increase of circulating plasma renin activity and increasing b
lood pressure. (2) by furosemide infusion with simultaneous salt subst
itution, increasing plasma renin activity values to 45 ng angiotensin
I/h per milliliter without changing blood pressure; or (3) by administ
ration of the calcium antagonist amlodipine, which increased plasma re
nin activity values to 42 ng angiotensin I/h per milliliter and lowere
d blood pressure. Unilateral renal artery clipping increased atrial na
triuretic peptide mRNA levels approximately 20-fold in the left ventri
cles and approximately twofold in the right ventricles and atria. Furo
semide infusion had no effect on cardiac atrial natriuretic peptide mR
NA levels, and in amlodipine-treated rats, cardiac atrial natriuretic
peptide mRNA levels decreased to 30% of control values. The increase o
f atrial natriuretic peptide mRNA in the ventricles during renal arter
y clipping was blunted by the administration of the angiotensin-conver
ting enzyme inhibitor ramipril, which also attenuated the blood pressu
re rise. In clipped rats amlodipine did not change elevated plasma ren
in activity values but abolished the rise of blood pressure and also a
ttenuated the rise of atrial natriuretic peptide mRNA in the hearts. T
hese findings indicate that an increase of the activity of the systemi
c renin-angiotensin system does not result in an obligatory change in
cardiac atrial natriuretic peptide expression. Moreover, our results s
uggest that activation renin-angiotensin system by renal artery stenos
is preferentially stimulates left ventricular atrial natriuretic pepti
de gene expression by an angiotensin II-dependent mechanism that could
be associated with the induction of myocardial hypertrophy.